Renin-angiotensin-aldosterone system and the aging kidney

Expert Review of Endocrinology and Metabolism

Volumn 9, Issue 6, 2014, Pages 543-546

  Musso, Carlos G ^a   Jauregui, José R ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

aging; aldosterone; angiotensin; renin; senescence

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CHEMOKINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENDOTHELIN 1; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MINERALOCORTICOID RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; SUPEROXIDE;

ACIDIFICATION; AGED; AGING; ANTIHYPERTENSIVE ACTIVITY; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; DEMENTIA; DIABETIC NEPHROPATHY; ENDOTHELIAL DYSFUNCTION; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; HEART FAILURE; HUMAN; HYPERTENSION; HYPONATREMIA; INFLAMMATION; KIDNEY DISTAL TUBULE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENESCENCE; SODIUM RESTRICTION; SODIUM URINE LEVEL; VASCULITIS;

EID: 84911470531     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/17446651.2014.956723     Document Type: Review

References (30)

1. Weidmann P, De Myttenaere-Bursztein S, Maxwell M, De Lima J. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 1975;8:325-33
2. Conti S, Cassi P, Benigni A. Aging and the renin-angiotensin system. Hypertension 2012;60:878-83
3. Belmin J, Lévy BI, Michel JB. Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging 1994;5(5):391-400
4. Corman B, Michel I. Renin-angiotensin system, converting-enzyme inhibition and kidney function in aging female rats. Am J Physiol 1986;251(3 Pt 2):R450-5
5. Musso CG, Oreopoulos D. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol 2011;119(Suppl 1): 1-5
6. Renkke H, Denker B. Renal pathophysiology. Lippincott Williams & Wilkins, Philadelphia; 2007
7. Andreucci VE, Russo D, Cianciaruso B, Andreucci M. Some sodium, potassium and water changes in the elderly and their treatment. Nephrol Dial Transplant 1996; 11(Suppl 9):9-17
8. Musso CG, Á lvarez Gregori J, Herrera Pérez del Villar J, et al. [Renal physiology in the advanced ageing process]. NefroPlus 2011;4(3):1-6
9. Musso CG, Núñez M, Algranati L. Fecal excretion of potassium in the elderly. FASEB J 2000;78
10. Schück O, Nádvornková H. Short acidification test and its interpretation with respect to age. Nephron 1987;46(2):215-16
11. Montanini V, Simoni M, Chiossi G, et al. Age-related changes in plasma dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men. Horm Res 1988; 29(1):1-6
12. Grim CE, Luft FC, Weinberger MH, et al. Genetic, familial and racial influences on blood pressure control systems in man. Aust N Z J Med 1984;14(4):453-7
13. Hilliard LM, Chow CL, Mirabito KM, et al. Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rat. Hypertension 2014;64(2): 378-83
14. Ferder LF, Inserra F, Basso N. Advances in our understanding of aging: role of the renin-angiotensin system. Curr Opin Pharmacol 2002;2(2):189-94
15. Ferder LF, Inserra F, Basso N. Effects of renin-angiotensin system blockade in the aging kidney. Exp Gerontol 2003;38(3): 237-44
16. Inserra F, Basso N, Ferder M, et al. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system. Ther Adv Cardiovasc Dis 2009; 3(5):341-6
17. de Cavanagh EM, Piotrkowski B, Basso N, et al. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 2003;17(9):1096-8
18. Basso N, Paglia N, Stella I, et al. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 2005;128(3):247-52
19. Basso N, Cini R, Pietrelli A, et al. Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol 2007;293(3):H1351
20. Ferder L, Martinez-Maldonado M. The renin-angiotensin system and the aging process. In: Mac?ás Núñez JF, Oreopoulos D, Cameron S, editors. The ageing kidney in health and disease. Springer, New York; 2008. pp. 208-30
21. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 2009;119(3):524-30
22. Cassis P, Conti S, Remuzzi G, Benigni A. Angiotensin receptors as determinants of life span. Pflugers Arch 2010;459(2):325-32
23. Perico N, Remuzzi G, Benigni A. Aging and the kidney. Curr Opin Nephrol Hypertens 2011;20(3):312-17
24. Marzolla V, Armani A, Zennaro MC, et al. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol Cell Endocrinol 2012;350(2):281-8
25. Musso CG, Alfie J. ACEIs as antihypertensives in the elderly (65 year old): a South American perspective. In: Onuigbo M, editor. ACE Inhibitors: medical uses, mechanisms of action, potential adverse effects and related topics. Volume 2. NOVA, 2013. pp. 129-34
26. Cavanagh E, Inserra F, Ferder L. Angiotensin II blockage: a strategy to slow ageing by protecting mitochondria? Cardiovasc Res 2011;89:31-40
27. Sánchez-Pozos K, Bobadilla NA. Is aldosterone a modulator of vascular tone? Rev Invest Clin 2012;64(6 Pt 1):546-57
28. O'Donnell E, Floras JS, Harvey PJ. Estrogen status and the renin angiotensin aldosterone system. Am J Physiol Regul Integr Comp Physiol 2014. [Epub ahead of print]
29. Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 2008;3(5):1511-25
30. Hajjar I, Brown L, Mack W, Chui H. Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series. Arch Neurol 2012; 69(12):1632-8